I  Illumina Accelerator

http://www.illumina.com/science/accelerator.h tml





     Office Locations:

451 El Camino Real, Suite 210
Santa Clara, CA 95050
Phone: 408-861-3610
Fax: 408-861-3630

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    The Illumina Accelerator Program is the world's first business accelerator focused on creating an innovation ecosystem for the genomics industry. Its goal is to speed the time to market and lower the barriers to entry for start-ups and early stage companies working on scientifically and commercially promising next-generation sequencing applications. Through the accelerator's six-month program, Illumina will provide participants with technology/business guidance, $100,000 in support, and access to lab space in close proximity to the company's R&D facilities in San Francisco's Mission Bay. Initial partners include technology investor Yuri Milner, who will offer each participating company $100,000 in exchange for convertible notes, and Silicon Valley Bank, which intends to provide banking services and credit to each participating company. Illumina will take a 10% common stock in startups that participate in the program.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Francis deSouza President
    Jay T. Flatley Chief Executive Officer
    Marc Stapley Senior Vice President and Chief Financial Officer
    Paul Bianchi Senior Vice President of Human Resources

     

    Portfolio companies include:


      Encoded Genomics
        web link


      EpiBiome
        web link


      Genizon Biosciences
        web link


      GenoLogics
        web link


      Human Longevity
        web link


      Oxford Nanopore Technologies
        web link


      Xcell Biosciences
        web link


     

    Recent News: